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Inadevelopingtissue,anumberofcellfatedecisionstakeplace:
stemcellsself-renew,progenitorcellsarebornandproliferateor
differentiate. We often consider in isolation two sets of factors
regulating these cell fate decisions: extracellular inﬂuences
such as ligands secreted by other cells, and cell-autonomous,
intracellular factors. Cell-autonomous factors can include
speciﬁc marker expression levels, or particular gene regulatory
programs. Increasingly, these intracellular factors are treated as
networks—signal transduction networks and gene regulatory
networks. The ligands regulating tissue development also form
a network (Frankenstein et al, 2006), connecting cells that
secrete them and cells that they target. How these two types of
networks, intracellular and extracellular, interact is still mostly
unknown. In a pioneering study just published in Molecular
Systems Biology, Kirouac et al (2010) connect the dots,
identifying speciﬁc cytokines as well as some of the crucial
intracellular network nodes involved in in vitro hematopoetic
stem cell maintenance, expansion, and differentiation.
The hematopoietic ‘tissue’ is composed of stem cells
(hematopoietic stem cells,HSCs), progenitorcells,and mature
cells differentiated into megakaryocytes, monocytes, and
erythrocytes. As long as the environment is favorable to their
proliferation, stem cells self-renew and give rise to progenitor
cells allowing maintenance or expansion of the tissue. To
successfully expand bone marrow or umbilical cord blood
in vitro to produce blood cells for clinical applications, the
regenerative potential of blood stem cells—their ability to self-
renew—must be maintained in a culture inevitably formed of
multiple blood cell types. These multiple cell types interact
through many secreted ligands and the maintenance of the
regenerative potential of blood stem cells is thought to be
regulated by multiple positive and negative feedbacks arising
from these cell–cell interactions between blood stem cells and
differentiated cells (Kirouac et al, 2009).
To identify the molecular players involved in feedback
regulation of HSC fate, Kirouac et al (2010) used a multipart
workﬂow that combined experiments, computational data
analysis, and data mining and that built on their previously
published dynamical model. First, they performed a differ-
entialscreenthatcomparedtranscriptionalandsecretedligand
proﬁles of culture conditions leading to either stem cell
expansion or stem cell depletion. This screen pointed them
to ligands that may promote or hinder the self-renewal
capacity of HSCs. Next, they used curated lists of ligand–re-
ceptor interactions and published transcriptional proﬁles of
distinct mature blood cell types to assign each ligand to its
source, and thus reconstruct the directionality of the cell–cell
interactions. Finally, to classify each ligand by mode of action,
Kirouac et al compared experimentally observed changes in
the cellular composition of cultured hematopoietic tissue after
adding each ligand, to theoretical dose–response model
predictions. CCL3, CCL4, TGFB, CXCL10, and TNFSF9 were
found to be secreted by monocytes and inhibit self-renewal
and proliferation of HSCs. On the other hand, EGF, PDGF,
VEGF, and 5HT1 are secreted by megakaryocytes and promote
stem cell self-renewal. Finally, three other ligands also
positively affect stem cell renewal (FLT3LG, KITL, THPO),
but their source could not be identiﬁed (Figure 1).
If we knew the important intracellular signaling proteins
responsible for the adaptation of blood stem cells to the
changing landscape of tissue composition and secreted
ligands, perhaps small molecule inhibitors could also be used
to optimize in vitro blood stem cell culture conditions.
By mining curated intracellular signaling networks, Kirouac
et al identiﬁed network hubs at the cross-roads of pathways
induced by the ligands in their hematopoiesis cell–cell
interaction network. As hubs, these signaling proteins may
act as integrators for several extracellular signals. Once more,
comparing cultures treated with chemical inhibitors with
model-predicted dose–responses, Kirouac et al assigned
functions to intracellular signaling hubs. Inhibitors of Raf
and PI3K were found to decrease the probability of the HSC
self-renewal, whereas inhibitors of Akt decreased the stem cell
proliferation rate. The function of MEK1 could not be deﬁned,
perhaps because it is context dependent, and, ﬁnally,
inhibitors of phospholipase C (PLC) clearly increased apopto-
sis rates within the blood cell cultures, indicating that its
activity is required for cell survival (Figure 1).
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is quite complex, it is undoubtedly a very simpliﬁed picture of
theinteractionsbetweenHSCsandothercells(Figure1).Inthe
body, ligands from solid tissues may help sustain blood stem
cell regenerative potential; indeed, neurological signals have
been found to inﬂuence hematopoetic stem cell fate
in vivo (Spiegel et al, 2008). Interestingly, Kirouac et al found
that, in vitro, the neurotransmitter serotonin (5HT1) is
secreted by megakaryocytes and positively inﬂuences HSC
expansion. Still, this does not rule out that in vivo there may
be multiple sources of serotonin and that blood marrow-
inﬁltrating neurons and other tissues might also secrete
ligands sustaining HSC expansion.
One question left unanswered in the study by Kirouac et al
is which cells are the targets of the chemical inhibitors
of intracellular signaling proteins: do inhibitors directly
affect stem cell behavior or do they change the cytokine
secretion patterns of mature cells in the culture, indirectly
affecting stem cell behavior? The answer is likely to be ‘all of
the above’ and only once we can selectively inactivate these
signaling proteins in individual cell types will a clearer
mechanistic picture of this network be deﬁned. In addition,
thetimeline ofsecretionand responsesto eachof theligands is
alsostill unknown—inwhich sequencedo theseligands acton
HSCs? How can we manipulate this sequence to optimize
in vitro cultures of blood cells? Finally, this signaling network
has only been deﬁned in terms of how it inﬂuences
whole population behavior. By adding single-cell approaches
to the arsenal of methods used by Kirouac et al, we will
eventually gain a much more complete understanding of the
mechanisms regulating hematopoietic cell expansion and
stem cell renewal.
Hematopoietic tissue, in addition to its clinical importance,
is particularly amenable to experiments because the cells can
be grown in well-mixed suspension cultures and their cell–cell
interactions may be predominantly (although certainly not
exclusively)throughdiffusibleligands.Inothertissues,spatial
organizationandcell–cellcontactsalsoinﬂuencedevelopment
and expansion. Nevertheless, the workﬂow developed by
Kirouac et al offers great potential for learning more of the
topology and the logic of extra- and intracellular networks
regulating the expansion and differentiation of other types of
stemcells.Greatchallengeslieahead,butKirouacetalmetthe
ﬁrst one, connecting a network that governs in vitro HSC
expansion, outside and in.
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Figure 1 Schematic diagram of extra- and intracellular signaling governing in vitro hematopoietic stem cell self-renewal identiﬁed by Kirouac et al (2010).
Hematopoietic stem cell expansion is bolstered by a positive feedback mechanism in which megakaryocytes secrete ligands that support hematopoietic stem cell self-
renewalandproliferation.Incontrast,monocytessecretefactorsthatarelinkedtostemcelldepletion.Thesemultipleextracellularsignalsareintegratedbycentralnodes
of an intracellular signaling network, which include Akt, PI3K, MEK2, Raf, and PLCs. Whether these intracellular network proteins are most important for the response of
stem cells to the extracellular ligands or for the secretory function of the differentiated cells is still unclear, although they most likely have a function in both.
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